Exploring multidimensional factors of herpes zoster risk in rheumatoid arthritis patients undergoing JAK inhibitor treatment

被引：0
|
作者：
Zhou, Lianwei [1 ]
Xing, Yuhe [1 ]
Li, Wenbo [1 ,2 ]
机构：
[1] Jiamusi Univ, Sch Clin Med, Jiamusi, Peoples R China
[2] Jiamusi Univ, Jiamusi, Heilongjiang, Peoples R China
来源：
CLINICAL RHEUMATOLOGY | 2024年 / 43卷 / 09期
关键词：
D O I：
10.1007/s10067-024-07076-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3033 / 3034
页数：2
相关论文
共 50 条
  • [31] Herpes Zoster and Tofacitinib Therapy in Patients with Rheumatoid Arthritis.
    Winthrop, K. L.
    Valdez, H.
    Mortensen, E.
    Chew, R.
    Krishnaswami, S.
    Kawabata, T.
    Riese, R.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1051 - S1051
  • [32] A JAK Inhibitor for Treatment of Rheumatoid Arthritis: The Baricitinib Experience
    Taylor, Peter C. C.
    Laedermann, Cedric
    Alten, Rieke
    Feist, Eugen
    Choy, Ernest
    Haladyj, Ewa
    de la Torre, Inmaculada
    Richette, Pascal
    Finckh, Axel
    Tanaka, Yoshiya
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (13)
  • [33] Hypertension and dyslipidemia are risk factors for herpes zoster in patients with rheumatoid arthritis: a retrospective analysis using a medical information database
    Keiko Tanaka
    Eizen Kimura
    Kensuke Oryoji
    Shin-ichi Mizuki
    Tomoko Kobayashi
    Atsushi Nishikawa
    Eiko Yoshinaga
    Yoshihiro Miyake
    Rheumatology International, 2021, 41 : 1633 - 1639
  • [34] Hypertension and dyslipidemia are risk factors for herpes zoster in patients with rheumatoid arthritis: a retrospective analysis using a medical information database
    Tanaka, Keiko
    Kimura, Eizen
    Oryoji, Kensuke
    Mizuki, Shin-ichi
    Kobayashi, Tomoko
    Nishikawa, Atsushi
    Yoshinaga, Eiko
    Miyake, Yoshihiro
    RHEUMATOLOGY INTERNATIONAL, 2021, 41 (09) : 1633 - 1639
  • [35] HYPOGLYCAEMIA FOLLOWING JAK INHIBITOR TREATMENT IN DIABETES MELLITUS PATIENTS WITH RHEUMATOID ARTHRITIS
    van Lint, J.
    Van Hunsel, F.
    Tas, S.
    Nurmohamed, M.
    Vonkeman, H.
    Hebing, R.
    Hoentjen, F.
    van Doorn, M.
    van den Bemt, B.
    van Puijenbroek, E.
    Jessurun, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 578 - 579
  • [36] RISK FOR HERPES ZOSTER AFTER TREATMENT WITH BIOLOGIC AND SYNTHETIC DISEASE MODIFYING AGENTS FOR RHEUMATOID ARTHRITIS
    Pappas, D. A.
    Hooper, M.
    Reed, G.
    Shan, Y.
    Wenkert, D.
    Zhang, J.
    Greenberg, J.
    Curtis, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 346 - 346
  • [37] Increased Risk of Herpes Zoster in Rheumatoid Arthritis Not Only Due to JAK Inhibitors-Study of 392 Patients from Single University Center
    Dominguez-Casas, Lucia C.
    Lasa-Teja, Carmen
    Ferraz-Amaro, Ivan
    Castaneda, Santos
    Blanco, Ricardo
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (11)
  • [38] Increased risk of herpes zoster with tofacitinib treatment in Korean patients with rheumatoid arthritis: a single-center prospective study
    Yeo-Jin Song
    Soo-Kyung Cho
    Hyoungyoung Kim
    Hye Won Kim
    Eunwoo Nam
    Ja-Young Jeon
    Hyun-Jeong Yoo
    Chan-Bum Choi
    Tae-Hwan Kim
    Jae-Bum Jun
    Sang-Cheol Bae
    Dae Hyun Yoo
    Yoon-Kyoung Sung
    Scientific Reports, 13
  • [39] Increased risk of herpes zoster with tofacitinib treatment in Korean patients with rheumatoid arthritis: a single-center prospective study
    Song, Yeo-Jin
    Cho, Soo-Kyung
    Kim, Hyoungyoung
    Kim, Hye Won
    Nam, Eunwoo
    Jeon, Ja-Young
    Yoo, Hyun-Jeong
    Choi, Chan-Bum
    Kim, Tae-Hwan
    Jun, Jae-Bum
    Bae, Sang-Cheol
    Yoo, Dae Hyun
    Sung, Yoon-Kyoung
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [40] Risk of Herpes Zoster in Patients with Rheumatoid Arthritis Treated with Anti TNF-alpha Agents
    Dejaco, C.
    Duftner, C.
    JOURNAL FUR MINERALSTOFFWECHSEL, 2009, 16 (03): : 142 - 143
12345